Biotech

Latest Articles

Cassava pays for $40M over presumably deceiving Alzheimer's upgrade

.Cassava Sciences has accepted pay for $40 million to address an inspection into cases it created de...

Merck bags alternatives on Evaxion's AI-designed vaccine applicants

.Merck &amp Co. has gotten options on pair of Evaxion Biotech vaccination candidates, paying $3.2 mi...

Enanta's RSV antiviral crushes virus-like lots in challenge study

.Enanta Pharmaceuticals has connected its own respiratory system syncytial virus (RSV) antiviral to ...

Biogen containers SAGE-324 cooperation after important tremor fall short

.Biogen has actually conducted the last rites to its cooperation along with Sage Rehabs on SAGE-324,...

AbbVie Parkinson's drug coming from $8.7 B Cerevel purchase ratings

.On the same time that some Parkinson's health condition drugs are being questioned, AbbVie has actu...

Arch closes $3B-plus fund to encourage biopharma startups

.On the heels of a $3 billion fund coming from Bain Resources Lifestyle Sciences, Arch Venture Allie...

Orion to make use of Aitia's 'digital doubles' to find new cancer medicines

.Finnish biotech Orion has actually snooped prospective in Aitia's "digital double" tech to cultivat...

Windtree's surprise med brings up blood pressure in newest period 2 win

.While Windtree Rehabs has strained to grow the economic roots needed to have to survive, a stage 2 ...

2 cancer biotechs combine, generating global footprint

.OncoC4 is actually taking AcroImmune-- and its own internal clinical manufacturing capabilities-- u...

Amgen records 1st stage 3 win for $400M chronic eczema drug

.Amgen has discussed (PDF) the first phase 3 records on its $400 million dermatitis medication, link...

Biogen, UCB file period 3 lupus gain after neglecting earlier trial

.Biogen and UCB's rely on developing in to stage 3 astride a failed research wants to have actually ...

Aptadir hopes new RNA preventions may turn around difficult cancers

.Italian biotech Aptadir Therapeutics has actually launched with the guarantee that its own pipeline...

Wave surfs DMD effectiveness to regulators' doors, delivering stockpile

.Surge Lifestyle Sciences has met its objective in a Duchenne muscular dystrophy (DMD) study, instal...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is going back to the pharma fold, occupyin...

Achilles drops cell treatment program, supports for layoffs after skipping 'business feasibility' objectives

.Achilles Therapeutics has actually destroyed its method. The English biotech is actually stopping w...

Aligos heralds period 2 MASH win, lowering liver body fat up to 46%

.Aligos Therapeutics is actually advertising a midstage succeed in metabolic-dysfunction associated ...

Basilea ratings $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work cultivating brand new antifungals has actually gotten a notable increa...

Capricor offers Europe liberties to late-stage DMD therapy for $35M

.Having presently scooped up the united state liberties to Capricor Therapeutics' late-stage Duchenn...

FDA fragments adcomm for Applied's unusual disease drug

.After pushing the selection meeting for Applied Therapeutics' metabolic disorder medication govores...

Novo inks $600M NanoVation deal to examine hereditary medications ex-liver

.Novo Nordisk is actually proceeding its press right into hereditary medications, agreeing to pay Na...